Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,715 | -16,925 | -12,524 | -8,145 | -3,860 |
| Depreciation Amortization | 280 | 1,076 | 782 | 501 | 240 |
| Accounts receivable | -314 | 261 | 261 | 261 | 270 |
| Accounts payable and accrued liabilities | -248 | 99 | -154 | -274 | -31 |
| Other Working Capital | -811 | -544 | -957 | -1,218 | -245 |
| Other Operating Activity | 1,358 | 2,335 | 2,240 | 1,708 | 414 |
| Operating Cash Flow | $-3,450 | $-13,698 | $-10,352 | $-7,167 | $-3,212 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 50,238 | -20,000 | 50,238 | 30,187 |
| PPE Investments | -145 | -1,274 | -987 | -678 | -296 |
| Purchase Of Investment | N/A | -20,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -42 | -25 | -12 | -6 |
| Other Investing Activity | 0 | -42 | 50,213 | -20,012 | -6 |
| Investing Cash Flow | $-145 | $28,922 | $29,226 | $29,548 | $29,885 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 803 | 1,874 | 1,474 | 1,474 | 1,474 |
| Financing Cash Flow | $803 | $1,874 | $1,474 | $1,474 | $1,474 |
| Exchange Rate Effect | -282 | -608 | -699 | -727 | -228 |
| Beginning Cash Position | 29,864 | 13,374 | 13,374 | 13,374 | 13,374 |
| End Cash Position | 26,790 | 29,864 | 33,023 | 36,502 | 41,293 |
| Net Cash Flow | $-3,074 | $16,490 | $19,649 | $23,128 | $27,919 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,450 | -13,698 | -10,352 | -7,167 | -3,212 |
| Capital Expenditure | -145 | -1,274 | -987 | -678 | -296 |
| Free Cash Flow | -3,595 | -14,972 | -11,339 | -7,845 | -3,508 |